Bioavailability Contamination Contract Manufacturing Development 
Pharmaceutical Technology
APRIL 12, 2023
Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. A robust manufacturing process that leads to a consistently high-quality product is a major business goal for pharmaceutical R&D.
Pharmaceutical Technology
JUNE 14, 2023
Containment challenges and opportunities High containment facilities guard against exposure to extremely potent products and cross-contamination. GlobalData’s Contract Small Molecule API Manufacturing Industry by the Numbers (2021) analyzed 2,787 small molecule API contract manufacturing facilities.
Expert insights. Personalized for you.
130 
Let's personalize your content